'''Antazoline''' is a 1st generation [[antihistamine]] with [[anticholinergic]] properties used to relieve [[nasal congestion]] and in [[eye drop]]s, usually in combination with [[naphazoline]], to relieve the symptoms of [[allergy|allergic]] [[conjunctivitis]].<ref>{{cite journal |journal = Am J Ophthalmol |year = 1980 |volume =90 |pages = 254–7 |title = Effects of topically applied ocular decongestant and antihistamine |vauthors=Abelson MB, Allansmith MR, Friedlaender MH |pmid=7425039 |issue=2 |doi=10.1016/s0002-9394(14)74864-0}}</ref> To treat allergic conjunctivitis, antazoline can be combined in a solution with [[tetryzoline]].<ref name="Castillo">{{cite journal |authors=Castillo M, Scott NW, Mustafa MZ, Mustafa MS, Azuara-Blanco A |title= Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis |journal=Cochrane Database Syst Rev|volume=6 |pages= CD009566 |date=2015 |pmid= 26028608 |doi= 10.1002/14651858.CD009566.pub2}}</ref> The drug is a [[Histamine H1 receptor]] antagonist:<ref>{{Cite journal|last=Noguchi|first=Seiji|last2=Inukai|first2=Toshiya|last3=Kuno|first3=Takayoshi|last4=Tanaka|first4=Chikako|title=The suppression of olfactory bulbectomy-induced muricide by antidepressants and antihistamines via histamine H1 receptor blocking|journal=Physiology & Behavior|volume=51|issue=6|pages=1123–1127|doi=10.1016/0031-9384(92)90297-f|pmid=1353628|date=June 1992}}</ref> selectively binding to but not activating the receptor, thereby blocking the actions of endogenous [[histamine]] and subsequently leading to the temporary relief of the negative symptoms brought on by histamine.
